PMCF Advises Plas-Tech Engineering on its Combination with H&T Presspart, a division of the Heitkamp & Thumann Group
has received an investment from
a division of
PMCF Investment Banking (“PMCF”) is pleased to announce that it served as the exclusive financial advisor to Plas-Tech Engineering (“Plas-Tech” or the “Company”) on its merger with H&T Presspart (“Presspart”), a division of the Heitkamp & Thumann Group.
Plas-Tech Engineering is recognized as a trusted partner for complex, high-precision medical components and devices. The company focuses on the design, development, and manufacturing of parenteral syringe systems and medical devices for the pharmaceutical and biotechnology industries leveraging advanced moulding technologies and design-for-manufacturing expertise to accelerate route-to-market of complex products.
The acquisition expands H&T Presspart’s manufacturing footprint into the United States and reinforces the company’s vision of being the most trusted and customer focused manufacturer of drug delivery devices in the world.
Christian Krätzig, President of H&T Presspart: “Plas-Tech Engineering is an excellent strategic fit for the H&T Presspart business. Plas-Tech’s proprietary portfolio of polymer prefilled syringe systems and its expertise in bespoke solutions for parenteral and medical device applications complements our offering and capabilities in the growing parenteral market. In addition, Plas-Tech’s site in Lake Geneva, WI opens new opportunities to serve our joint customer base globally.”
Aaron Hirschmann, President and CTO of Plas-Tech Engineering: “With its long-standing experience in the development and manufacturing of components and devices for the global pharmaceutical industry, H&T Presspart is the right home for Plas-Tech and its employees. Together, we will create strong synergies and drive shared growth.”
PMCF served as the Company’s exclusive financial advisor in the transaction. Aaron commented, “I greatly appreciate the expertise and guidance John and his team at PMCF provided throughout the process. We have been working with the PMCF team since 2019, and I have known John for over ten years. PMCF’s long-term approach to transaction planning, in-depth knowledge of the plastics industry, and excellent client service were critical as I navigated this once in a lifetime transaction. I would enthusiastically recommend PMCF to other plastics companies considering a transaction, whether in the near term or the future.”
Managing Director of PMCF’s Plastics & Packaging Group, John Hart, commented on the transaction, “We’ve had the privilege of working with Aaron and the PTE team for many years and are thrilled with the outcome of this transaction. H&T Presspart offers an excellent platform for this combination, and we look forward to seeing the continued success of the unified organization.”
About PMCF Investment Banking
PMCF is a client-centric middle market investment bank providing merger and acquisition advisory services to privately held shareholders as well as public, and private equity owned companies worldwide. The firm combines expansive industry and transactional expertise with highly engaged, senior-level bankers to create tailored solutions for clients. PMCF has been serving the plastics and packaging industries for over 20 years and has a long track record of successful transactions involving specialty, niche players in these industries. For more information about PMCF, please visit www.pmcf.com
About H&T Presspart
H&T Presspart is a leading developer and manufacturer of drug delivery devices and components. With over 50 years of experience, it has built a global reputation for expertise, quality, and innovation in the pharmaceutical industry. With a wide portfolio of components, device solutions and services, H&T Presspart partners to deliver exceptional customer experience and accelerated routes to market of customers’ drug-device programs. H&T Presspart has 4 European manufacturing sites in Germany, Spain, Switzerland, and the UK and has sales representation in China, India, the USA, and Uruguay. For more information, please visit www.presspart.com.
About The Heitkamp & Thumann Group
The Heitkamp & Thumann Group is a leading global partner for the development and supply of world class precision formed components, devices and services. Our products reach a large number of the global population on a daily basis – in portable energy, electro-mobility and health. Established in 1978, our family-owned company has grown into a dynamic Group of companies, encompassing three innovative Divisions and three supportive Business Units strategically located in nine countries and on three continents. For more information, please visit www.ht-group.com.
About Plas-Tech Engineering
Plas-Tech Engineering is a full-scale medical device manufacturer providing end-to-end support from early development to production. With 35+ years of experience, Plas-Tech has grown from precision molding into a vertically-integrated partner offering concept development, prototyping and tooling, injection molding, assembly, and validations for both low- and high-volume needs. The company has been recognized as a leading injection molder having won Wisconsin Manufacturer of the Year in 2024 and was acknowledged as a Top Shop by Plastics Technology in 2025. For more information, please visit www.plastechengineering.com.
Plas-Tech’s Equinox brand delivers proprietary pre-fillable syringes engineered for evolving needs in drug delivery, combining advanced materials and customizable features for biologics and high-viscosity formulations. For more information, please visit www.equinoxsyringes.com.
